Hemophilia B Leyden
Hemophilia B Leyden (HBL) is a rare subtype of hemophilia B, a genetic bleeding disorder characterized by the lack of a blood clotting protein called factor IX (FIX). For most peop...
Search fresh public links, source activity, and ready-to-use post angles for Hemophilia B.
Fresh curated links around hemophilia B are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Hemophilia B Leyden (HBL) is a rare subtype of hemophilia B, a genetic bleeding disorder characterized by the lack of a blood clotting protein called factor IX (FIX). For most peop...
Factor VIII (FVIII) replacement therapy is a cornerstone of treatment for many people with hemophilia A, a rare bleeding disorder caused by deficient or dysfunctional FVIII, a prot...
A look at how FVIII/FIX deficiency contributes to variable disease severity and provides the biologic foundation for modern hemophilia therapies. The post Bleeding Response in Hemo...
Inside hemophilia genetics, such as F8 and F9 mutations, inheritance patterns, and de novo variants. Plus, evolving approaches to females with hemophilia. The post Hemophilia As an...
Rebinyn (nonacog beta pegol) is a recombinant factor IX concentrate used to prevent and treat bleeds, including those occurring during surgery, in children and adults with hemophil...
Hemophilia is a rare disorder in which the blood doesn’t clot properly, resulting in the disease’s hallmark symptoms of bleeds — excessive bleeding that extends over a prolonged pe...
Hemophilia A, a genetic bleeding disorder, is often underdiagnosed in women because of the historical misconception that it affects only men due to its inheritance pattern. While w...
Xyntha (moroctocog alfa) is a recombinant clotting factor replacement therapy approved to prevent and treat bleeds, including those occurring during surgery, in people with hemophi...
Albumin fusion is a molecular technology that has been used to create replacement therapies for hemophilia with an extended half-life — treatments that are more long-lasting in the...
There is no cure for hemophilia A, but several treatments are available to help prevent and control bleeds, reduce the risk of complications, and improve quality of life. People wi...
Factor deficiencies can disrupt clot formation, causing bleeding complications, arthropathy, the development of inhibitors, and long-term disease burden. The post Management Challe...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.